Toxic shock syndrome in Australian children
- 26 April 2016
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 101 (8) , 736-740
Abstract
Background There are limited data describing the epidemiology, management and outcomes of children with toxic shock syndrome (TSS), a potentially life-threatening illness. Here, we describe the incidence, clinical features, treatment and outcome of children with staphylococcal and streptococcal TSS in Victoria, Australia. Methods Retrospective chart review of children admitted between 2003 and 2014 to two tertiary paediatric referral centres who fulfilled the Centers for Disease Control and Prevention case definition of TSS. Results There were 62 cases over the 11-year period; 43 staphylococcal TSS and 19 streptococcal TSS. The majority (46 (74%)) of cases were admitted to an intensive care unit and 44 (71%) required inotropic support. Compared with those with staphylococcal TSS, patients with streptococcal TSS were younger, more unwell and more likely to have residual morbidity. Adjunctive therapy with intravenous immunoglobulin or clindamycin was used in 58 (94%) of cases and fresh frozen plasma was used in 15 (24%). Seven patients received extracorporeal membrane oxygenation. All patients survived. Conclusions This study highlights the importance of early recognition of TSS and supports rapid tertiary referral and intensive care management, which includes the use of adjunctive therapy with intravenous immunoglobulin and clindamycin.Keywords
This publication has 21 references indexed in Scilit:
- Invasive Group A Streptococcal DiseaseDrugs, 2012
- Staphylococcal Toxic Shock Syndrome 2000–2006: Epidemiology, Clinical Features, and Molecular CharacteristicsPLOS ONE, 2011
- Intravenous Immunoglobulin in Children with Streptococcal Toxic Shock SyndromeClinical Infectious Diseases, 2009
- SevereStreptococcus pyogenesInfections, United Kingdom, 2003–2004Emerging Infectious Diseases, 2008
- Severe complications of chickenpox in hospitalised children in the UK and IrelandArchives of Disease in Childhood, 2007
- Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammationJournal of Antimicrobial Chemotherapy, 2006
- Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled TrialClinical Infectious Diseases, 2003
- Epidemiology of Invasive Group AStreptococcusDisease in the United States, 1995–1999Clinical Infectious Diseases, 2002
- Invasive Group A Streptococcal Disease in Children and Association With Varicella-Zoster Virus InfectionPediatrics, 2000
- Intravenous Immunoglobulin Therapy for Streptococcal Toxic Shock Syndrome—A Comparative Observational StudyClinical Infectious Diseases, 1999